CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Net service revenue	$ 557,988	$ 553,485	$ 1,661,135	$ 1,654,795
Other operating income	0	(4)	0	13,300
Cost of service, excluding depreciation and amortization	322,227	310,294	943,258	916,188
General and administrative expenses:
Salaries and benefits	125,550	119,373	376,788	349,533
Non-cash compensation	3,495	4,397	15,990	17,860
Other	59,299	55,158	167,851	158,995
Depreciation and amortization	5,477	7,487	19,705	21,763
Investment impairment	3,009	0	3,009	0
Operating expenses	519,057	496,709	1,526,601	1,464,339
Operating income	38,931	56,772	134,534	203,756
Other income (expense):
Interest income	59	0	108	49
Interest expense	(4,963)	(2,730)	(16,447)	(6,734)
Equity in earnings (loss) from equity method investments	302	1,444	(442)	3,932
Gain on equity method investments	0	0	0	31,092
Miscellaneous, net	491	490	1,155	1,253
Total other (expense) income, net	(4,111)	(796)	(15,626)	29,592
Income before income taxes	34,820	55,976	118,908	233,348
Income tax expense	(9,417)	(10,731)	(32,755)	(57,192)
Net income	25,403	45,245	86,153	176,156
Net loss (income) attributable to noncontrolling interests	239	(239)	739	(1,131)
Net income attributable to Amedisys, Inc.	$ 25,642	$ 45,006	$ 86,892	$ 175,025
Basic earnings per common share:
Net income attributable to Amedisys, Inc. common stockholders, basic (usd per share)	$ 0.79	$ 1.38	$ 2.67	$ 5.36
Weighted average shares outstanding, basic (shares)	32,482	32,607	32,519	32,658
Diluted earnings per common share:
Net income attributable to Amedisys, Inc. common stockholders, diluted (usd per share)	$ 0.79	$ 1.37	$ 2.66	$ 5.30
Weighted average shares outstanding, diluted (shares)	32,616	32,899	32,680	33,021